235 related articles for article (PubMed ID: 36288387)
1. The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer.
Huang J; Zhou W; Hao C; He Q; Tu X
PLoS Genet; 2022 Oct; 18(10):e1010366. PubMed ID: 36288387
[TBL] [Abstract][Full Text] [Related]
2. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
3. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
4. SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition.
Chen W; Jiang T; Mao H; Gao R; Zhang H; He Y; Liu C; Chen Q
Hum Cell; 2020 Jul; 33(3):737-749. PubMed ID: 32207096
[TBL] [Abstract][Full Text] [Related]
5. Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells.
Zhang N; Hua X; Tu H; Li J; Zhang Z; Max C
Cancer Lett; 2021 Nov; 520():400-408. PubMed ID: 34332039
[TBL] [Abstract][Full Text] [Related]
6. MiR-186-5p suppresses cell migration, invasion, and epithelial mesenchymal transition in bladder cancer by targeting RAB27A/B.
Zhang Q; Hao L; Shen Z; Wang F; Han C
Environ Toxicol; 2021 Nov; 36(11):2174-2185. PubMed ID: 34291859
[TBL] [Abstract][Full Text] [Related]
7. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
[TBL] [Abstract][Full Text] [Related]
8. METTL14-Mediated miR-30c-1-3p Maturation Represses the Progression of Lung Cancer via Regulation of MARCKSL1 Expression.
Li F; Zhao J; Wang L; Chi Y; Huang X; Liu W
Mol Biotechnol; 2022 Feb; 64(2):199-212. PubMed ID: 34586620
[TBL] [Abstract][Full Text] [Related]
9. m
Liu P; Fan B; Othmane B; Hu J; Li H; Cui Y; Ou Z; Chen J; Zu X
Theranostics; 2022; 12(14):6291-6307. PubMed ID: 36168624
[TBL] [Abstract][Full Text] [Related]
10. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
[TBL] [Abstract][Full Text] [Related]
11. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
Lin S; Wang L; Shi Z; Zhu A; Zhang G; Hong Z; Cheng C
Bioengineered; 2021 Dec; 12(2):11376-11389. PubMed ID: 34852712
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
Wang JR; Liu B; Zhou L; Huang YX
Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
[TBL] [Abstract][Full Text] [Related]
14. MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.
Xu M; Li J; Wang X; Meng S; Shen J; Wang S; Xu X; Xie B; Liu B; Xie L
Cell Death Dis; 2018 Feb; 9(2):209. PubMed ID: 29434190
[TBL] [Abstract][Full Text] [Related]
15. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
[TBL] [Abstract][Full Text] [Related]
16. The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.
Huang J; Lo UG; Wu S; Wang B; Pong RC; Lai CH; Lin H; He D; Hsieh JT; Wu K
Cell Death Dis; 2019 Jun; 10(6):437. PubMed ID: 31164632
[TBL] [Abstract][Full Text] [Related]
17. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer.
Wang W; Jiang X; Xia F; Chen X; Li G; Liu L; Xu Q; Zhu M; Chen C
Mol Biol Rep; 2023 Jan; 50(1):453-464. PubMed ID: 36348197
[TBL] [Abstract][Full Text] [Related]
18. METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.
Chen JX; Chen DM; Wang D; Xiao Y; Zhu S; Xu XL
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36960869
[TBL] [Abstract][Full Text] [Related]
19. ZEB1-mediated biogenesis of circNIPBL sustains the metastasis of bladder cancer via Wnt/β-catenin pathway.
Li Y; Kong Y; An M; Luo Y; Zheng H; Lin Y; Chen J; Yang J; Liu L; Luo B; Huang J; Lin T; Chen C
J Exp Clin Cancer Res; 2023 Aug; 42(1):191. PubMed ID: 37528489
[TBL] [Abstract][Full Text] [Related]
20. METTL14-mediated m
Fan HN; Chen ZY; Chen XY; Chen M; Yi YC; Zhu JS; Zhang J
Mol Cancer; 2022 Feb; 21(1):51. PubMed ID: 35164771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]